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We show that the production of Luminol reactive oxygen radicals in the perfused rat heart under ischemia nd reperfusion can be monitored contin- 
uously by measuring the chemiluminescence of Luminol-perfused hearts. Luminol did not affect the monitored physiological parameters of the 
hearts. Chemiluminescence increased uring ischemia and reperfusion. Superoxide dismutase treatment of the heart before ischemia, but not cata- 
lase, abolished these increases. 
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1. INTRODUCTION 
Reactive oxygen radical formation during ischemia- 
reperfusion is currently considered to be an important 
cause of tissue damage in the heart [l-3]. Most of the 
evidence for this is indirect and based on the ability of 
radical scavengers to decrease the adverse consequences 
of standardized ischemia-reperfusion protocols [4-61. 
Quantitative and continuous measurement of radical 
production in tissue would enable a rigorous study of 
the time course of radical production, effect of phar- 
macological agents on radical production, analysis of 
any direct correlations between the extent of radical 
production and tissue damage and the development of 
rational intervention strategies. 
Oxygen radicals and their paramagnetic reaction 
products with tissue constituents or spin trapping 
agents can be determined through electron 
paramagnetic resonance (EPR) of frozen tissue samples 
[7-lo] or using spin trapping agents to form stable 
derivatives of the radicals followed by EPR examina- 
tion [l l-141. Taken together, these studies indicate that 
myocardial radical production increases during pro- 
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longed ischemia and that there is a large burst of radical 
production immediately on the onset of reperfusion. 
Another method for detection of reactive oxygen 
species in tissue is the measurement of the low level 
chemiluminescence that is emitted by the tissue as a con- 
sequence of the reactions of the oxygen radicals. Some 
of this chemiluminescence may be due to hemoglobin or 
myoglobin assisted breakdown of reactive oxygen 
species possibly with concomitant lipid peroxidation 
[ 151. We and others have previously studied the low 
level chemiluminescence of perfused liver and other 
similar systems [16,17]. While we have detected 
chemiluminescence changes during ischemia-reperfu- 
sion studies of the heart and liver, the low intensity of 
the spontaneous chemiluminescence makes quantitative 
studies difficult. 
Oxygen radical production by neutrophils has been 
studied by monitoring chemiluminescence in the 
presence of chemicals such as Luminol (5-amino-2,3- 
dihydrophthalazine-1 ,Cdione) that react with oxygen 
radicals and produce chemiluminescence with a higher 
quantum yield [18,19]. The use of such chemical eads 
to large increases in sensitivity and is well established in 
cellular immunology. For example, the elegant studies 
of inhibitor and effector sensitivity of Luminol- 
enhanced chemiluminescence of monocytes and 
granulocytes by Dahlgren and coworkers show the in- 
volvement of myeloperoxidase reactions in the che- 
miluminescent process as well as the presence of 
separate intracellular and extracellular processes 
[20-221. We describe here the first application of the 
Luminol-enhanced chemiluminescence t chnique to the 
isolated perfused rat heart during ischemia-reperfusion 
to study oxygen radical production in this system. 
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2. MATERIALS AND METHODS 
2.1. Animal preparation 
(CAT) (100 U/ml of perfusion buffer, 5 hearts) was administered for 
10 min before and 30 min following ischemia along with the Luminol 
perfusion buffer (Group II and Group III, respectively). 
Sprague-Dawley rats (280-320 g body weight) were injected with 
sodium heparin (1000 U/kg i.p.) and anesthetized 30 min later with 
sodium pentobarbital (50 mg/kg i.p.). The heart was rapidly excised 
and placed in ice-cold perfusion medium. The heart was then can- 
nulated through the aorta and retrograde perfused as per the Lagen- 
dorff procedure at a constant perfusion pressure of 100 cm HsO. The 
perfusion buffer used was a modified Krebs-Henseleit bicarbonate 
buffer solution (KH buffer), pH 7.4, consisting of the following (in 
mM): NaCl 118, KC1 4.7, KHzP04 1.25, CaCl2 1.25, MgSO4 1.25, 
NaHCOs 24.0 and glucose 11.1. The temperature of the perfusion 
buffer was 37°C. The perfusion buffer was gassed continuously with 
a mixture of 95% 02, 5% COZ and was filtered through a 0.45 fi 
Millipore filter. A teflon catheter was inserted into the left ventricle 
through the left atrium to monitor the left ventricular systolic (LVSP) 
and diastolic (LVDP) pressure. Coronary flow (CF) was measured by 
collection of the effluent perfusate at timed intervals. Chemicals and 
enzymes used were obtained from Sigma. The specific activity of SOD 
(from bovine liver) was 3000 U/mg protein and that of catalase (from 
bovine liver) was 3650 U/mg protein. 
The LEC intensity and the physiological parameters were 
monitored continuously through the course of the experiment. 
3. RESULTS 
Fig. 1 shows the chemiluminescence r sponse of KH 
perfused and KHL perfused isolated rat heart to 
ischemia and reperfusion. The KH perfused heart 
shows very weak chemiluminescence that decreases on 
the onset of ischemia; the chemiluminescence r covers 
on reperfusion. However, the signal-to-noise ratio is 
too low for any detailed analysis. The KHL perfused 
heart shows a vastly improved signal-to-noise ratio and 
the time course of the changes in LEC can be clearly 
and quantitatively followed. 
2.2. Detection of chemiluminescence 
The rat heart under perfusion was enclosed in a light-tight perfu- 
sion box. The box was designed so that all manipulations could be 
carried out from the outside eliminating artifacts arising out of ex- 
posure of the photomultiplier to light. Chemiluminescence was 
measured by an EMI 9658 photomultiplier cooled to - 2O”C, at an 
applied potential of 0.95 kV. Standard high performance photon 
counting electronics consisting of a low-noise preamplifier, amplifier, 
discriminator and ratemeter were used. Dark counts were around 60 
cps .
2.3. Ischemia protocol 
The LVDP, LVSP and CF values of the hearts did 
not change significantly on changing from KH to KHL 
buffer; following these parameters in control isolated 
perfused hearts over several hours did not show any dif- 
ferences between the KH perfused and KHL perfused 
hearts. No significant differences were seen between the 
3 groups in terms of LVSP, LVDP or CF behavior in 
response to the 30 min ischemia-reperfusion. This sug- 
gests that the inclusion of Luminol in the perfusion 
buffer did not significantly affect the monitored 
physiological variables of the hearts. 
The hearts were perfused for 10 min with the KH buffer. Then, the 
perfusion buffer was changed to KH buffer containing 0.2 gM 
Luminol (KHL buffer) for the rest of the experiment. Five of the 
hearts were subjected to 30 min of global ischemia by stopping the 
flow of the perfusion buffer. The ischemic period was followed by 
reperfusion for 1 h (Group I). In separate xperiments, superoxide 
dismutase (SOD) (30 U/ml of perfusion buffer, 5 hearts) or catalase 
The reproducibility of the changes in LEC, expressed 
as percent changes from their pre-ischemic value, was 
good with deviations of not more than 10% within any 
group. Fig. 2 shows typical LEC traces of hearts during 
ischemia-reperfusion when perfused with KHL buffer, 
KHL-SOD buffer and KHL-CAT buffer. The heart 
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Fig. 1. Comparison of isolated perfused rat heart chemiluminescence hanges in response to ischemia-reperfusion. Trace A; heart perfused with 
KH buffer (no Luminol). Trace B: heart perfused with KHL buffer (with Luminol). 
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Fig. 2. Typical Luminol-enhanced chemiluminescence r sponses of 
the isolated rat heart perfused with KHL buffer. Group I, heart with 
no additional chemical treatment; Group II, heart with SOD treat- 
ment; Group III, heart with CAT treatment. For all the hearts, KH 
buffer was replaced by KHL buffer 10 min after the beginning of the 
measurement, at point A; ‘treatment’ shows the period through which 
SOD or CAT was administered. 
perfused in KHL buffer shows an increase in LEC 
beginning at about 15 min of ischemia and reaches a 
value about 70% higher than the pre-ischemic level; 
reperfusion leads to a further increase in LEC to about 
120% above the pre-ischemic level. In the heart perfus- 
ed with KHL-SOD buffer, the increases in LEC are en- 
tirely abolished; further, the LEC levels during 
ischemia are lower than the pre-ischemic levels. The 
hearts perfused with KHL-CAT buffer showed 
behavior similar to the hearts perfused with KHL 
buffer. 
4. DISCUSSION REFERENCES 
The ischemia-reperfusion protocol used in this series 
of experiments was mild enough that there were no per- 
manent changes in LVDP, LVSP or CF on reperfusion. 
Hence, if oxygen radicals are the agents causing 
ischemia-reperfusion damage, they were produced only 
in lower concentrations than necessary to cause serious 
tissue damage. The experimental system is sufficiently 
sensitive that we are able to follow the production of 
oxygen radicals through LEC measurements con- 
tinuously and with good signal-to-noise ratios and 
statistics. It may be noted that the LEC intensities 
presented are an instantaneous measure of the oxygen 
radical concentration. Integrated over time, the LEC 
values provide a quantitative measure of total oxygen 
radical production. 
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[ 1,4]. A similar protocol can also be applied to other 
tissues such as perfused liver (Okuda, M., Ikai, I., 
Chance, B. and Kumar, C., manuscript in preparation). 
Why is SOD so effective in abolishing LEC increases 
in the perfused heart during ischemia-reperfusion but 
not CAT? The first possibility is that the oxygen radical 
that is produced in significant amounts is superoxide; 
hydrogen peroxide is produced only at rates well below 
the maximal rates at which the tissue is capable of con- 
verting peroxide to oxygen or oxygen radicals so that 
added CAT has little effect on LEC intensities. The sec- 
ond possibility, that Luminol is sensitive only to 
superoxide and not to peroxide is excluded from the 
studies of mechanism of Luminol chemiluminescence, 
though some selectivity towards superoxide is known 
[19,23]. 
Lastly, it may be noted that significant production of 
oxygen radicals occurred in our studies not only during 
reperfusion but also during ischemia. Despite nominal 
global ischemia, enough oxygen enters the tissue, 
possibly assisted by myoglobin, through diffusion from 
the air that the condition is similar to low-flow ischemia 
and, it seems, conducive to superoxide production. 
Tissue oxygen pOz of the order of 1 mM Hg has been 
shown to be sufficient for the production of radicals in 
the ischemic myocardium [24]. 
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